摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(苯磺酰)-1H-吲哚-2-甲醛 | 80360-23-2

中文名称
1-(苯磺酰)-1H-吲哚-2-甲醛
中文别名
1-(苯基磺酰基)-1H-吲哚-2-甲醛
英文名称
1-(phenylsulfonyl)-1H-indole-2-carbaldehyde
英文别名
1-phenylsulfonylindole-2-carboxaldehyde;1-(phenylsulfonyl)indole-2-carbaldehyde;1-(benzenesulfonyl)indole-2-carbaldehyde
1-(苯磺酰)-1H-吲哚-2-甲醛化学式
CAS
80360-23-2
化学式
C15H11NO3S
mdl
——
分子量
285.323
InChiKey
NWVOBVXBWUGTTO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    111 °C
  • 沸点:
    513.6±42.0 °C(Predicted)
  • 密度:
    1.31±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    20
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    64.5
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 危险品标志:
    Xi
  • 安全说明:
    S24/25
  • 海关编码:
    2933990090

SDS

SDS:c61d3fa280551a35e2cefa61002267cf
查看
Name: 1-(Phenylsulfonyl)-1h-indole-2-carbaldehyde 97% Material Safety Data Sheet
Synonym:
CAS: 80360-23-2
Section 1 - Chemical Product MSDS Name:1-(Phenylsulfonyl)-1h-indole-2-carbaldehyde 97% Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
80360-23-2 1-(Phenylsulfonyl)-1H-indole-2-carbald 97% unlisted
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
May cause respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Store under an inert atmosphere.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 80360-23-2: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: yellow
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 110 - 112 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C15H11NO3S
Molecular Weight: 285.32

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, oxides of sulfur, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 80360-23-2 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-(Phenylsulfonyl)-1H-indole-2-carbaldehyde - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 80360-23-2: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 80360-23-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 80360-23-2 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
    • 3
    • 4
    • 5

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Novel Bis(1H-indol-2-yl)methanones as Potent Inhibitors of FLT3 and Platelet-Derived Growth Factor Receptor Tyrosine Kinase
    摘要:
    FLT3 receptor tyrosine kinase is aberrantly active in many cases of acute myeloid leukemia (AML). Recently, bis(1H-indol-2-yl) methanones were found to inhibit FLT3 and PDGFR kinases. To optimize FLT3 activity and selectivity, 35 novel derivatives were synthesized and tested for inhibition of FLT3 and PDGFR autophosphorylation. The most potent FLT3 inhibitors 98 and 102 show IC50 values of 0.06 and 0.04 mu M, respectively, and 1 order of magnitude lower PDGFR inhibiting activity. The derivatives 76 and 82 are 20- to 40- fold PDGFR selective. Docking at the recent FLT3 structure suggests a bidentate binding mode with the backbone of Cys-694. Activity and selectivity can be related to interactions of one indole moiety with a hydrophobic pocket including Phe-691, the only different binding site residue (PDGFR Thr-681). Compound 102 inhibited the proliferation of 32D cells expressing wildtype FLT3 or FLT3-ITD similarly as FLT3 autophosphorylation, and induced apoptosis in primary AML patient blasts.
    DOI:
    10.1021/jm058033i
  • 作为产物:
    描述:
    N-甲氧基-N-甲基-1H-吲哚-2-甲酰胺 在 lithium aluminium tetrahydride 、 18-冠醚-6potassium tert-butylate 作用下, 以 四氢呋喃 为溶剂, 反应 6.25h, 生成 1-(苯磺酰)-1H-吲哚-2-甲醛
    参考文献:
    名称:
    构象,空间和电子效应对N-双(三甲基甲硅烷基)甲基,N-(2-吲哚基)甲基α-重氮酰胺金属催化反应的位点和化学选择性的影响†
    摘要:
    研究了N-双(三甲基甲硅烷基)甲基,N-(2-吲哚基)甲基α-重氮酰胺的Rh(II)和Cu(II)催化反应,以描述构象,空间和电子因素如何影响位点和金属类化合物反应的化学选择性。所述Ñ双(三甲基硅烷基)甲基(Ñ -BTMSM)基团被发现是在促进在所述metallocarbenoid反应必需ñ - (2-吲哚基)甲基部分,以及提供有关酰胺N-C微妙但有效的构象的影响α在携带N-C重氮酯σ键α烷氧基甲基侧链,具有出色的位点和化学选择性。通常,发现金属催化的反应有利于在吲哚C(2)-C(3)双键上的金属碳氢化合物加成-C-H,从而得到环丙烷化产物(四环γ-内酰胺)。然而,化学选择性还受空间效应,如在显示Ñ - [2-(3- methylindolyl)]甲基重氮酯,以及由该催化剂所采用的性质在一定程度上,如在该N-C α-烷氧基甲基重氮酰胺。发现四环γ-内酰胺在金属碳烯化合物反应条件下或在酸性条
    DOI:
    10.1039/c2ob25103e
点击查看最新优质反应信息

文献信息

  • Nickel-Catalyzed Isomerization/Allylic Cyanation of Alkenyl Alcohols
    作者:Ying Ding、Jinguo Long、Feilong Sun、Xianjie Fang
    DOI:10.1021/acs.orglett.1c02143
    日期:2021.8.6
    Herein reported is a nickel-catalyzed isomerization/allylic cyanation of alkenyl alcohols, which complements current methods for the allylic substitution reactions. The specific diphosphite ligand and methanol as the solvent are crucial for the success for this transformation. A gram-scale regioconvergent experiment and formal synthesis of quebrachamine demonstrate the high potential of this methodology
    本文报道了烯醇的催化异构化/烯丙基化,它补充了当前用于烯丙基取代反应的方法。特定的二亚磷酸配体和作为溶剂的甲醇对于这种转化的成功至关重要。克级区域会聚实验和 quebrachamine 的正式合成证明了这种方法的巨大潜力。
  • A one-pot “back-to-front” approach for the synthesis of benzene ring substituted indoles using allylboronic acids
    作者:Ganesh Karan、Samrat Sahu、Modhu Sudan Maji
    DOI:10.1039/d1cc01512e
    日期:——
    Synthesis of only benzene ring functionalized indoles and poly-substituted carbazoles is reported via a one-pot triple cascade benzannulation protocol. Usage of differently substituted and readily accessible allylboronic acids as a 3-carbon annulating partner enables diverse aliphatic and aromatic substitution patterns, which is still a daunting task. This scalable synthetic protocol tolerates broad
    通过一锅三重级联苯环化方案报道了仅苯环官能化的吲哚和多取代的咔唑的合成。使用不同取代和易于获得的烯丙基硼酸作为3碳环化伙伴可以实现多种脂族和芳族取代模式,这仍然是一项艰巨的任务。这种可扩展的合成协议具有宽泛的范围,因此可以进行进一步的下游修改。作为一种应用,合成了咔唑类天然产物糖唑啉和糖唑啉醇。
  • Total Synthesis of Bioactive Indolo[3,2-j]phenanthridine Alkaloid, Calothrixin B
    作者:Satoshi Hibino、Tominari Choshi、Shigeo Tohyama、Kohji Matsumoto、Akira Yamabuki、Yuhzo Hieda、Junko Nobuhiro
    DOI:10.3987/com-10-s(e)11
    日期:——
    The total synthesis of bioactive calothrixin B (2) was completed which two kinds of carbazoles using three approaches. The common strategy was based on an allene-mediated electrocyclic reaction of a 6π-electron system involving one or two indole [b]-bonds for the construction of an appropriate 4-oxygenated 2,3,4-trisubstituted carbazole 28 or a 6-oxygenated 5-methylindolo[2,3-a]carbazole 39, respectively
    采用三种途径完成了两种咔唑生物活性环丝素B(2)的全合成。常见的策略是基于丙二烯介导的 6π-电子系统的电环反应,涉及一个或两个吲哚 [b]-键,用于构建适当的 4-氧化 2,3,4-三取代咔唑 28 或 6-含氧 5-甲基吲哚并[2,3-a]咔唑 39,分别。将 28 的甲基氧化,然后将 21 的硝基还原,得到五环苯酚 5,用 CAN 氧化得到 calothrixin B (2)。在仿生途径中,具有甲氧基甲基基团的完全保护的 5-甲酰基吲哚并[2,3-a]咔唑 40 通过 N-甲氧基甲基-calothrixin B 43 提供了 calothrixin B (2)。
  • Synthesis of tetrahydrofurocarbazolones via intramolecular Diels-Alder reactions
    作者:Jose S. Madalengoitia、Timothy L. Macdonald
    DOI:10.1016/s0040-4039(00)73719-1
    日期:1993.9
    10-Aryl-3a,4,10,10a-tetrahydrofuro[3,4-b]carbazol-1-ones were synthesized by an intramolecular Diels-Alder reaction. Exo/endo product ratios were found to be sensitive to both solvent and temperature. The synthesis of isoelliptitoxin 2, a hybrid molecule of ellipticine and 4'-demethylpodophyllotoxin, is presented.
    通过分子内Diels-Alder反应合成了10-芳基-3a,4,10,10a-四氢呋喃[3,4-b]咔唑-1-酮。发现外/内产物的比率对溶剂和温度均敏感。介绍了玫瑰树碱和4'-去甲基鬼臼毒素的杂合分子异椭圆毒素2的合成。
  • A Convenient Synthesis of 1,2-Dihydro-3<i>H</i>-indol-3-ones and 1,2-Dihydro-2<i>H</i>-indol-2-ones by Baeyer-Villiger Oxidation
    作者:A. S. Bourlot、E. Desarbre、J. Y. Mérour
    DOI:10.1055/s-1994-25488
    日期:——
    The Baeyer-Villiger rearrangement of substituted 1H-indole-3-carbaldehydes afforded the corresponding substituted 1,2-dihydro-3H-indol-3-ones. The influence of 3-carbonyl and 1-protecting groups has been examined. Reaction has been extended to 1H-indole-2-carbaldehydes and used for synthesis of 1-(phenylsulfonyl)-1H-indol-2-yl trifluoromethanesulfonate.
    取代的1H-吲哚-3-甲醛在Baeyer-Villiger重排作用下,得到了相应的取代的1,2-二氢-3H-吲哚-3-酮。研究了3-羰基和1-保护基团的影响。该反应已扩展到1H-吲哚-2-甲醛,并用于合成1-(苯磺酰基)-1H-吲哚-2-基三氟甲磺酸酯。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫